Coronado Biosciences, Inc. (NASDAQ:CNDO) reported the formation of a new subsidiary company, Checkpoint Therapeutics, Inc., to develop a portfolio of fully human immuno-oncology targeted antibodies generated in the laboratory of Dr. Wayne Marasco, MD, PhD, a Professor in the Department of Cancer Immunology and AIDS at Dana-Farber Cancer Institute (Dana-Farber). On Thursday shares of Coronado Biosciences, Inc. (NASDAQ:CNDO) closed at $3.37. Company’s EPS growth for next 5 years is recorded as 26.20%.
China New Borun Corporation (NYSE: BORN) announced its unaudited financial results for the fourth quarter and full-year ended December 31 2014. Total revenue decreased 7.3% to RMB610.0 million ($99.7 million1) from RMB657.8 million in the fourth quarter of 2013. China New Borun Corporation (NYSE:BORN) in last trading activity increased 6.16% to close at $1.55. Company weekly performance is 29.17% while its quarterly performance stands at -3.13%. China New Borun Corporation (NYSE:BORN) is -64.04% away from its 52 week high.
HeartWare International, Inc. (NASDAQ: HTWR) announced that CEO Doug Godshall is scheduled to present at the 2015 Barclays Global Healthcare Conference at 8:00 a.m. Eastern Time on Tuesday, March 10, 2015. On last trading day Heartware International Inc. (NASDAQ:HTWR) increased 1.43% to close at $85.89. Its volatility for the week is 2.17% while volatility for the month is 2.20%. HTWR’s sales growth for past 5 years was 270.00% and its EPS growth for past 5 years was -4.20%. Heartware International Inc. (NASDAQ:HTWR) monthly performance is 0.13%.
PGT, Inc. (PGTI – Snapshot Report) reported a 33% year-over-year decline in its fourth-quarter earnings to 8 cents per share on Feb 25. Net sales in the quarter grew 37% year over year to $85 million, outperforming management’s guidance of $81 to $84 million. Revenue also came ahead of the Zacks Consensus Estimate of $80 million. Sales growth included 10% organic growth and a contribution of $12.7 million from the CGI acquisition. PGT, Inc. (NASDAQ:PGTI) has 7.28% insider ownership while its institutional ownership stands at 90.60%. In last trading activity company’s stock closed at $11.19.
Facebook Inc. (NASDAQ:FB) is trying to induce improvements in the mechanism through which it can detect fake profiles. All social networking websites are concerned with issues plaguing the platform’s security and as well as user identities. Facebook’s CEO, Mark Zuckerberg, is concerned that this may damage the reputation of the company. On Thursday shares of Facebook Inc (NASDAQ:FB) closed at $81.21. Company’s sales growth for last 5 years was 74.20% and EPS growth for next 5 years is recorded as 31.46%.